Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000964363 | SCV001111562 | likely benign | not provided | 2019-12-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004029914 | SCV003543337 | uncertain significance | not specified | 2021-07-21 | criteria provided, single submitter | clinical testing | The c.3119C>T (p.T1040I) alteration is located in exon 18 (coding exon 18) of the PER3 gene. This alteration results from a C to T substitution at nucleotide position 3119, causing the threonine (T) at amino acid position 1040 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Breakthrough Genomics, |
RCV000964363 | SCV005263788 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV003916153 | SCV004735008 | benign | PER3-related disorder | 2019-06-19 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |